Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Jun;44(6):1598-603.
doi: 10.1128/AAC.44.6.1598-1603.2000.

Mild heating of amphotericin B-desoxycholate: effects on ultrastructure, in vitro activity and toxicity, and therapeutic efficacy in severe candidiasis in leukopenic mice

Affiliations

Mild heating of amphotericin B-desoxycholate: effects on ultrastructure, in vitro activity and toxicity, and therapeutic efficacy in severe candidiasis in leukopenic mice

E W van Etten et al. Antimicrob Agents Chemother. 2000 Jun.

Abstract

Heated (20 min at 70 degrees C) amphotericin B-desoxycholate (hAMB-DOC) was further characterized, as was another formulation obtained after centrifugation (60 min, 3000 x g), hcAMB-DOC. Conventional AMB-DOC consisted of individual micelles (approximately 4 nm in diameter) and threadlike aggregated micelles, as revealed by cryo-transmission electron microscopy. For both hAMB-DOC and hcAMB-DOC, pleiomorphic cobweb structures were observed with a mean particle size of approximately 300 nm as determined by laser diffraction. The potent antifungal activity of AMB-DOC against Candida albicans is not reduced by heating. Effective killing of C. albicans (>99.9% within 6 h) was obtained at 0.1 mg/liter with each of the AMB formulations. For AMB-DOC, hAMB-DOC, and hcAMB-DOC, cation release ((86)Rb(+)) from C. albicans of > or =50% was observed at 0.8, 0.4, and 0.4 mg/liter, respectively. After heating of AMB-DOC, toxicity was reduced 16-fold as determined by red blood cell (RBC) lysis. For AMB-DOC, hAMB-DOC, and hcAMB-DOC, hemolysis of > or =50% was observed at 6.4, 102.4, and 102.4 mg/liter, respectively. In contrast, AMB-DOC and its derivates showed similar toxicities in terms of cation release from RBC. For AMB-DOC, hAMB-DOC, and hcAMB-DOC, cation release ((86)Rb(+)) of > or =50% was observed at 1.6, 0.8, and 0.8 mg/liter, respectively. In persistently leukopenic mice with severe invasive candidiasis, higher dosages of both hAMB-DOC and hcAMB-DOC were tolerated than those of conventional AMB-DOC (3 versus 0.8 mg/kg of body weight, respectively), resulting in significantly improved therapeutic efficacy. In conclusion, this new approach of heating AMB-DOC may be of great value for further optimizing the treatment of severe fungal infections.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Cryo-transmission electron micrographs of small threadlike micelles of AMB-DOC (arrows) (A), pleiomorphic cobweb structures of hAMB-DOC (arrow) (B), and hcAMB-DOC, which has an appearance similar to that of hAMB-DOC (arrow) (C). Regions of higher density near hole edges indicate thicker ice. Bars = 50 nm (A and C) and 60 nm (B).
FIG. 1
FIG. 1
Cryo-transmission electron micrographs of small threadlike micelles of AMB-DOC (arrows) (A), pleiomorphic cobweb structures of hAMB-DOC (arrow) (B), and hcAMB-DOC, which has an appearance similar to that of hAMB-DOC (arrow) (C). Regions of higher density near hole edges indicate thicker ice. Bars = 50 nm (A and C) and 60 nm (B).
FIG. 2
FIG. 2
(A) Effects of AMB-DOC and its derivates on ion fluxes in yeast cells (C. albicans). The release of 86Rb+ caused by various concentrations of AMB-DOC (●), hAMB-DOC (▴), and hcAMB-DOC (▾) was measured as described in Materials and Methods. Data points are means of triplicate determinations. (B) Effects of AMB-DOC and its derivates on ion fluxes (closed symbols) and hemolysis (open symbols) of erythrocytes. The release of 86Rb+ and the hemolysis induced by various concentrations of AMB-DOC (● and ○), hAMB-DOC (▴ and ▵), and hcAMB-DOC (▾ and ▿) were determined as described in Materials and Methods. Data points are means of triplicate determinations.
FIG. 3
FIG. 3
Effect of early (A) or delayed (B) treatment with AMB-DOC or its derivates on survival rates of persistently leukopenic mice with severe invasive candidiasis (Kaplan-Meier plot). Leukopenic mice were inoculated i.v. at time zero with 3 × 104 CFU of C. albicans. (A) Groups of 10 animals each were treated i.v. 6 h after C. albicans inoculation with a single dose of AMB-DOC (●), hAMB-DOC (▴), or hcAMB-DOC (▾) at 0.8 mg of AMB/kg. (B) Mice were treated 16 h after C. albicans inoculation with a single dose of AMB-DOC (●) at 0.1 mg of AMB/kg or with hAMB-DOC (▴) or hcAMB-DOC (▾), each at 0.6 mg of AMB/kg. Controls were treated with placebo (5-DW) (■). #, P ≤ 0.05 versus placebo-treated mice; ∗, P ≤ 0.001 versus placebo-treated mice.

Similar articles

Cited by

References

    1. Gaboriau F, Chéron M, Leroy L, Bolard J. Physicochemical properties of the heat induced ‘super’ aggregates of amphotericin B. Biophys Chem. 1997;66:1–12. - PubMed
    1. Gaboriau F, Chéron M, Petit C, Bolard J. Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index. Antimicrob Agents Chemother. 1997;41:2345–2351. - PMC - PubMed
    1. Hiemenz J W, Walsh T J. Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis. 1996;22(Suppl. 2):S133–S144. - PubMed
    1. Juliano R L, Grant C W M, Barber K R, Kalp M A. Mechanism of the selective toxicity of amphotericin B incorporated into liposomes. Mol Pharmacol. 1987;31:1–11. - PubMed
    1. Leenders A C, de Marie S. The use of lipid formulations of amphotericin B for systemic fungal infections. Leukemia. 1996;10:1570–1575. - PubMed